KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Capital Leases: 2020-2021

Historic Capital Leases for Ginkgo Bioworks Holdings (DNA) over the last 2 years, with Dec 2021 value amounting to $22.3 million.

  • Ginkgo Bioworks Holdings' Capital Leases rose 267.85% to $59.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $59.8 million, marking a year-over-year increase of 267.85%. This contributed to the annual value of $22.3 million for FY2021, which is 34.90% up from last year.
  • Ginkgo Bioworks Holdings' Capital Leases amounted to $22.3 million in FY2021, which was up 34.90% from $16.5 million recorded in FY2020.
  • Ginkgo Bioworks Holdings' Capital Leases' 5-year high stood at $22.3 million during FY2021, with a 5-year trough of $16.5 million in FY2020.
  • Its 2-year average for Capital Leases is $19.4 million, with a median of $19.4 million in 2020.
  • Data for Ginkgo Bioworks Holdings' Capital Leases shows a peak YoY skyrocketed of 34.90% (in 2021) over the last 5 years.
  • Ginkgo Bioworks Holdings' Capital Leases (Yearly) stood at $16.5 million in 2020, then spiked by 34.90% to $22.3 million in 2021.